Cell therapy biotech Arcellx made its public debut on Friday, raising $124M to bankroll multiple myeloma CAR-T study. LATEST IPOS AND… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3453721/-Opening-Day-Arcellx-raises-M-in-Wall-Street-debut)